Heartland Advisors Inc. Makes New Investment in Teleflex Incorporated $TFX

Heartland Advisors Inc. acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 211,848 shares of the medical technology company’s stock, valued at approximately $26,854,000. Teleflex accounts for approximately 1.2% of Heartland Advisors Inc.’s investment portfolio, making the stock its 7th biggest position. Heartland Advisors Inc. owned 0.50% of Teleflex as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. BlackRock Inc. bought a new position in Teleflex during the second quarter valued at about $688,537,000. Janus Henderson Group PLC raised its position in Teleflex by 1.1% in the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock worth $513,281,000 after acquiring an additional 45,199 shares during the period. AQR Capital Management LLC raised its position in Teleflex by 478.1% in the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after acquiring an additional 1,956,811 shares during the period. State Street Corp boosted its stake in Teleflex by 1.5% in the fourth quarter. State Street Corp now owns 1,478,776 shares of the medical technology company’s stock valued at $180,470,000 after acquiring an additional 22,111 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Teleflex by 0.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,250,665 shares of the medical technology company’s stock valued at $152,630,000 after acquiring an additional 5,051 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Stock Up 3.0%

TFX opened at $138.99 on Friday. The company has a 50 day moving average of $132.70 and a 200 day moving average of $124.73. The company has a market cap of $5.89 billion, a PE ratio of -5.97, a price-to-earnings-growth ratio of 0.90 and a beta of 0.81. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $145.00. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.48. The business had revenue of $570.33 million for the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The business’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 7.26 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be paid a $0.34 dividend. The ex-dividend date is Friday, August 14th. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is currently -5.84%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Sunday, August 9th. Piper Sandler reiterated an “overweight” rating and issued a $169.00 price objective (up from $160.00) on shares of Teleflex in a research note on Friday, August 7th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Needham & Company LLC boosted their target price on Teleflex from $147.00 to $159.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Finally, Mizuho upped their price target on Teleflex from $140.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $151.80.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.